In this episode of The Swine Health Blackbelt Podcast, Dr. Dirk Werling, a leading expert in molecular immunology and vaccine technology, shares insights into the future of vaccine development in swine health. As the Center for Vaccinology and Regenerative Medicine director at the Royal Veterinary College, University of London, Dr. Werling discusses the revolutionary approaches his team is exploring to enhance vaccine efficacy. Tune into this episode on major platforms to discover how these innovations could reshape swine health management."Combining our knowledge about the microbiome with new vaccines, we can eliminate the need for prophylactic antibiotics." - Dr. Dirk WerlingMeet the guest: Dr. Dirk Werling, Professor of Molecular Immunology and Director at the Centre for Vaccinology and Regenerative Medicine at the Royal Veterinary College, U. of London, brings over 18 years of expertise in innate immunity and vaccine development. His research, funded by prestigious organizations, aims to revolutionize vaccine platforms for farm animals.00:00) Highlights(01:20) Introduction(02:40) Vaccine Futures(03:55) Vaccine vs. Antibiotics(06:00) Microfluidics in Vaccines(06:50) Organ Platforms(09:10) Tissue-Based Models(14:00) Closing InsightsThe Swine Health Blackbelt Podcast is trusted and supported by innovative companies like:* Boehringer Ingelheim* Elanco- Healthy Climate Solutions- Cloudfarms- Essential Ag Solutions𝗟𝗶𝘀𝘁𝗲𝗻 𝗼𝗻 𝗔𝗽𝗽𝗹𝗲 𝗣𝗼𝗱𝗰𝗮𝘀𝘁𝘀, 𝗦𝗽𝗼𝘁𝗶𝗳𝘆 𝗼𝗿 𝗮𝗻𝘆 𝗺𝗮𝗷𝗼𝗿 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺.Instagram: Swine CampusLinkedIn: Swine CampusWebsite: swinehealthblackbelt.com

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related